Rate-dependent effect of verapamil on atrial refractoriness

Journal of the American College of Cardiology

Volumn 41, Issue 3, 2003, Pages 446-451

  Hassan, Sohail A ^a   Oral, Hakan ^a   Scharf, Christoph ^a   Chugh, Aman ^a   Pelosi, Frank ^a   Knight, Bradley P ^a   Adam Strickberger, S ^a   Morady, Fred ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERAPAMIL;

ADULT; ARTICLE; ATRIAL EFFECTIVE REFRACTORY PERIOD; CALCIUM CURRENT; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEASUREMENT; NORMAL HUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REFRACTORY PERIOD;

EID: 0037419872     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02771-7     Document Type: Article

References (23)

1. Ehara T, Daufmann R. The voltage- and time-dependent effects of (-)-verapamil on the slow inward current in isolated cat ventricular myocardium. J Pharmacol Exp Ther 1978;207:49-55.
2. Jose AD, Taylor RR. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969;48:2019-31.
3. Wagner JG, Rocchini AP, Vasiliades J. Prediction of steady-state verapamil plasma concentrations in children and adults. Clin Pharmacol Ther 1982;32:172-81.
4. Reiter MJ, Shand DG, Aanonsen LM, Wagoner R, McCarthy E, Pritchett EL. Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen. Am J Cardiol 1982;50:716-21.
5. Ca at physiological temperatures and relevance to action potential. Am J Physiol 1997;272:H227-35.
6. Zhang S, Zhou Z, Gong Q, Makielski JC, January CT. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. Circ Res 1999;84:989-98.
7. Benardeau A, Fareh S, Nattel S, Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs. Cardiovasc Res 2001;50:85-96.
8. Daoud EG, Knight BP, Weiss R, et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-50.
9. Duytschaever M, Garratt C, Allessie M. Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:1375-85.
10. Ramanna H, Elvan A, Wittkampf FH, de Bakker JM, Hauer RN, Robles de Medina EO. Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation. J Am Coll Cardiol 2001;37:1403-7.
11. Sticherling C, Hsu W, Tada H, et al. Effects of verapamil and ibutilide on atrial fibrillation and post-fibrillation atrial refractoriness. J Cardiovasc Electrophysiol 2002;13:151-7.
12. Capucci A, Biffi M, Boriani G, et al. Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995;92:1193-202.
13. Kim KB, Rodefeld MD, Schuessler RB, Cox JL, Boineau JP. Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium. Circulation 1996;94:2961-7.
14. Shenasa M, Kus T, Fromer M, LeBlanc R, Dubuc M, Nadeau R. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 1988;62:403-7.
15. Platia EV, Michelson EL, Porterfield JK, Das G. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 1989;63:925-9.
16. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-74.
17. Tieleman RG, De Langen C, Van Gelder IC, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-53.
18. Daoud EG, Hummel JD, Augostini R, Williams S, Kalbfleisch SJ. Effect of verapamil on immediate recurrence of atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:1231-7.
19. De Simone A, Stabile G, Vitale DF, et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999;34:810-4.
20. Ellenbogen KA, German LD, O'Callaghan WG, et al. Frequency-dependent effects of verapamil on atrioventricular nodal conduction in man. Circulation 1985;72:344-52.
21. Talajic M, Nattel S. Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: demonstration and characterization in anesthetized dogs. Circulation 1986;74:1156-67.
22. Morady F, Kadish AH, Toivonen LK, Kushner JA, Schmaltz S. The maximum effect of an increase in rate on human ventricular refractoriness. Pacing Clin Electrophysiol 1988;11:2223-34.
23. Hancox JC, Patel KC, Jones JV. Antiarrhythmics - from cell to clinic: past, present, and future. Heart 2000;84:14-24.